Advertisement

Microchimica Acta

, 186:719 | Cite as

Spectrophotometric and visual determination of zoledronic acid by using a bacterial cell-derived nanopaper doped with curcumin

  • Shadab Faham
  • Raouf GhavamiEmail author
  • Hamed GolmohammadiEmail author
  • Gholamreza Khayatian
Original Paper
  • 56 Downloads

Abstract

A nanopaper-based analytical device (NAD) is described for a colorimetric metal-complexing indicator-displacement assay (M-IDA) for zoledronic acid (ZA). Bacterial cellulose nanopaper was doped with curcumin to obtain a chemosensor on which hydrophilic test zones were patterned via laser printing of hydrophobic walls. The color intensity of the test zones decreases in the presence of Fe(III) due to the formation of Fe(III)-curcumin complex. However, upon addition of ZA, Fe(III) ions preferably binds ZA. Subsequently, the color of the zone changes from light yellow to dark yellow. The changes in the absorption (measured at 427 nm) and of the color of the test stripe can be monitored visually, by using a digital camera, or by a spectrophotometer. Under optimal conditions, the analytical signals increase linearly in the 0.01–100 μM ZA concentration range, and the detection limits are 8.8 and 8.0 nM for smartphone and spectrophotometer-based methods, respectively. The method was employed to the determination of ZA in (spiked) urine, serum, saliva, and in pharmaceutical samples.

Graphical abstract

Schematic representation of a nanopaper-based analytical device based on curcumin-doped BC nanopaper (CDBC) integrated with smartphone for metal-complexing indicator-displacement assay of zoledronic acid (ZA). High affinity of ZA to Fe(III) on the NAD/CDBC leads to color change.

Keywords

Cellulose nanopaper Colorimetric Curcumin Zoledronic acid 

Notes

Acknowledgements

The authors are grateful for the financial support of the University of Kurdistan for this study.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Supplementary material

604_2019_3815_MOESM1_ESM.docx (273 kb)
ESM 1 (DOCX 273 kb)

References

  1. 1.
    Himelstein AL, Foster JC, Khatcheressian JL, Roberts JD, Seisler DK, Novotny PJ, Qin R, Go RS, Grubbs SS, O’connor T (2017) Effect of longer-interval vs standard dosing of zoledronic acid on skeletal events in patients with bone metastases: a randomized clinical trial. Jama 317(1):48–58CrossRefGoogle Scholar
  2. 2.
    Khalafallah A, Slancar M, Cosolo W, Abdi E, Chern B, Woodfield R, Copeman M, Briscoe K, Catley L, Chirgwin J (2018) Long-term safety of monthly zoledronic acid therapy beyond 1 year in patients with advanced cancer involving bone (LoTESS): a multicentre prospective phase 4 study. Eur J Cancer Care 27(2):e12638CrossRefGoogle Scholar
  3. 3.
    Raje N, Vescio R, Montgomery CW, Badros A, Munshi N, Orlowski R, Hadala JT, Warsi G, Argonza-Aviles E, Ericson SG (2016) Bone marker–directed dosing of zoledronic acid for the prevention of skeletal complications in patients with multiple myeloma: results of the Z-MARK study. Clin Cancer Res 22(6):1378–1384CrossRefGoogle Scholar
  4. 4.
    Tai T-W, Chen C-Y, Su F-C, Tu Y-K, Tsai T-T, Lin C-F, Jou I-M (2017) Reactive oxygen species are required for zoledronic acid-induced apoptosis in osteoclast precursors and mature osteoclast-like cells. Sci Rep 7:44245CrossRefGoogle Scholar
  5. 5.
    Comito G, Segura CP, Taddei ML, Lanciotti M, Serni S, Morandi A, Chiarugi P, Giannoni E (2017) Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts. Oncotarget 8(1):118–132CrossRefGoogle Scholar
  6. 6.
    Ubellacker JM, Baryawno N, Severe N, DeCristo MJ, Sceneay J, Hutchinson JN, Haider M-T, Rhee CS, Qin Y, Gregory WM (2018) Modulating bone marrow hematopoietic lineage potential to prevent bone metastasis in breast cancer. Cancer Res 78(18):5300–5314CrossRefGoogle Scholar
  7. 7.
    Honda Y, Aikata H, Honda F, Nakano N, Nakamura Y, Hatooka M, Morio K, Kobayashi T, Fukuhara T, Nagaoki Y (2017) Clinical outcome and prognostic factors in hepatocellular carcinoma patients with bone metastases medicated with zoledronic acid. Hepatol Res 47(10):1053–1060CrossRefGoogle Scholar
  8. 8.
    Veldboer K, Vielhaber T, Ahrens H, Hardes J, Streitbürger A, Karst U (2011) Determination of zoledronic acid in human urine and blood plasma using liquid chromatography/electrospray mass spectrometry. J Chromatogr B 879(22):2073–2080CrossRefGoogle Scholar
  9. 9.
    Faro AFL, Giorgetti R, Busardò FP, Lodi G, Martini V, Pispero A, Iriti M, Varoni EM (2019) Development and validation of a method using ultra performance liquid chromatography coupled to tandem mass spectrometry for determination of zoledronic acid concentration in human bone. J Pharm Biomed Anal 162:286–290CrossRefGoogle Scholar
  10. 10.
    Legay F, Gauron S, Deckert F, Gosset G, Pfaar U, Ravera C, Wiegand H, Schran H (2002) Development and validation of a highly sensitive RIA for zoledronic acid, a new potent heterocyclic bisphosphonate, in human serum, plasma and urine. J Pharm Biomed Anal 30(4):897–911CrossRefGoogle Scholar
  11. 11.
    Amin N, Afkhami A, Hosseinzadeh L, Madrakian T (2018) Green and cost-effective synthesis of carbon dots from date kernel and their application as a novel switchable fluorescence probe for sensitive assay of Zoledronic acid drug in human serum and cellular imaging. Anal Chim Acta 1030:183–193CrossRefGoogle Scholar
  12. 12.
    Schoolaert E, Hoogenboom R, De Clerck K (2017) Colorimetric nanofibers as optical sensors. Adv Funct Mater 27(38):1702646CrossRefGoogle Scholar
  13. 13.
    Nguyen BT, Anslyn EV (2006) Indicator–displacement assays. Coord Chem Rev 250(23–24):3118–3127CrossRefGoogle Scholar
  14. 14.
    Zor E (2018) Silver nanoparticles-embedded nanopaper as a colorimetric chiral sensing platform. Talanta 184:149–155CrossRefGoogle Scholar
  15. 15.
    Rodríguez-Sevilla E, Vázquez GV, Morales-Narváez E (2018) Simple, flexible, and ultrastable surface enhanced raman scattering substrate based on plasmonic nanopaper decorated with graphene oxide. Adv Optical Mater 6(19):1800548CrossRefGoogle Scholar
  16. 16.
    Solin K, Orelma H, Borghei M, Vuoriluoto M, Koivunen R, Rojas OJ (2018) Two-dimensional antifouling fluidic channels on nanopapers for biosensing. Biomacromolecules 20:1036–1044CrossRefGoogle Scholar
  17. 17.
    Raj S, Shankaran DR (2016) Curcumin based biocompatible nanofibers for lead ion detection. Sens Actuators B Chem 226:318–325CrossRefGoogle Scholar
  18. 18.
    Thomas B, Raj MC, Joy J, Moores A, Drisko GL, Sanchez C (2018) Nanocellulose, a versatile green platform: from biosources to materials and their applications. Chem Rev 118(24):11575–11625CrossRefGoogle Scholar
  19. 19.
    Golmohammadi H, Morales-Narvaez E, Naghdi T, Merkoci A (2017) Nanocellulose in sensing and biosensing. Chem Mater 29(13):5426–5446CrossRefGoogle Scholar
  20. 20.
    Morales-Narváez E, Golmohammadi H, Naghdi T, Yousefi H, Kostiv U, Horak D, Pourreza N, Merkoçi A (2015) Nanopaper as an optical sensing platform. ACS Nano 9(7):7296–7305CrossRefGoogle Scholar
  21. 21.
    Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA (2017) The essential medicinal chemistry of curcumin: miniperspective. J Med Chem 60(5):1620–1637CrossRefGoogle Scholar
  22. 22.
    Borsari M, Ferrari E, Grandi R, Saladini M (2002) Curcuminoids as potential new iron-chelating agents: spectroscopic, polarographic and potentiometric study on their Fe (III) complexing ability. Inorganica Chim Acta 328(1):61–68CrossRefGoogle Scholar
  23. 23.
    Pourreza N, Golmohammadi H (2015) Hemoglobin detection using curcumin nanoparticles as a colorimetric chemosensor. RSC Adv 5(3):1712–1717CrossRefGoogle Scholar
  24. 24.
    Pourreza N, Sharifi H, Golmohammadi H (2016) Curcumin nanoparticles combined with cloud point extraction for citrate determination in food and drug samples. Microchem J 129:213–218CrossRefGoogle Scholar
  25. 25.
    Naghdi T, Golmohammadi H, Vosough M, Atashi M, Saeedi I, Maghsoudi MT (2019) Lab-on-nanopaper: an optical sensing bioplatform based on curcumin embedded in bacterial nanocellulose as an albumin assay kit. Anal Chim Acta 1070:104–111CrossRefGoogle Scholar
  26. 26.
    Raccor BS, Sun J, Lawrence RF, Li L, Zhang H, Somerman MJ, Totah RA (2013) Quantitation of zoledronic acid in murine bone by liquid chromatography coupled with tandem mass spectrometry. J Chromatogr B 935:54–60CrossRefGoogle Scholar
  27. 27.
    Burmaoglu RE, Saglik Aslan S (2018) Determination of Zoledronic acid and its related substances by high performance liquid chromatography with evaporative light scattering detection. J Chromatogr Sci 57(1):33–43Google Scholar
  28. 28.
    Jiang Y, Zhang X, Xu Z (2004) Analysis of zoledronic acid and its related substances by ion-pair RP-LC. Chromatographia 60(7–8):405–409CrossRefGoogle Scholar
  29. 29.
    Rao BM, Srinivasu M, Rani CP, Kumar PR, Chandrasekhar K, Veerender M (2005) A validated stability indicating ion-pair RP-LC method for zoledronic acid. J Pharm Biomed Anal 39(3–4):781–790CrossRefGoogle Scholar
  30. 30.
    Xie Z, Jiang Y, Zhang D-q (2006) Simple analysis of four bisphosphonates simultaneously by reverse phase liquid chromatography using n-amylamine as volatile ion-pairing agent. J Chromatogr A 1104(1–2):173–178CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Chemistry Department, Faculty of ScienceUniversity of KurdistanSanandajIran
  2. 2.Chemistry and Chemical Engineering Research Center of IranTehranIran

Personalised recommendations